
2023-2029 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Research & Trends Analysis Report
Discover the latest insights into the booming Benign Prostatic Hyperplasia (BPH) Laser Therapy Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report, the global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Benign Prostatic Hyperplasia (BPH) Laser Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Benign Prostatic Hyperplasia (BPH) Laser Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Holmium Laser segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Benign Prostatic Hyperplasia (BPH) Laser Therapy include Boston Scientific, Agiliti Health, Inc., Endo Pharmaceuticals Inc., HealthTronics, Inc., OmniGuide, Olympus Corporation, Richard Wolf GmbH, Lumenis and Urologix, LLC, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
BPH or benign prostatic hyperplasia or hypertrophy is a benign enlargement of the prostate.BPH Laser Therapy is a minimally invasive procedure for BPH (benign prostatic hyperplasia) that uses laser energy to remove enlarged prostate tissue, resulting in an open channel for urine flow-through and a quick return to a life with dramatically improved BPH symptoms.Benign prostate hyperplasia (BPH), while not cancer, can causes symptoms such as bladder stones, blood in the urine and an inability to urinate.
This report aims to provide a comprehensive study of the global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy. Report Highlights:
(1) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Benign Prostatic Hyperplasia (BPH) Laser Therapy market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy segment by type and by application and regional segment by type and by application.
(6) Benign Prostatic Hyperplasia (BPH) Laser Therapy industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Holmium Laser
Thulium Laser
Green Light Laser
Others
Market segment by application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Boston Scientific
Agiliti Health, Inc.
Endo Pharmaceuticals Inc.
HealthTronics, Inc.
OmniGuide
Olympus Corporation
Richard Wolf GmbH
Lumenis
Urologix, LLC
Coloplast Corp
Medifocus Inc.
Biolitec
Teleflex Incorporated
Urotech Devices
BD
PROCEPT BioRobotics
1 Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Laser Therapy
1.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size and Forecast
1.3 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Share in Global Market, 2018-2029
1.4.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size: China VS Global, 2018-2029
1.5 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Dynamics
1.5.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Drivers
1.5.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Restraints
1.5.3 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Trends
1.5.4 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Policy
2 Global Competitive Situation by Company
2.1 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company (2018-2023)
2.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Concentration Ratio
2.4 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Mergers & Acquisitions, Expansion Plans
2.5 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company (2018-2023)
3.2 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Benign Prostatic Hyperplasia (BPH) Laser Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Benign Prostatic Hyperplasia (BPH) Laser Therapy, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Chain
4.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Upstream Analysis
4.3 Benign Prostatic Hyperplasia (BPH) Laser Therapy Midstream Analysis
4.4 Benign Prostatic Hyperplasia (BPH) Laser Therapy Downstream Analysis
5 Sights by Type
5.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Classification
5.1.1 Holmium Laser
5.1.2 Thulium Laser
5.1.3 Green Light Laser
5.1.4 Others
5.2 By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029
6 Sights by Application
6.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Segment by Application
6.1.1 Hospitals
6.1.2 Clinics
6.1.3 Others
6.2 By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
7.3 North America
7.3.1 North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.4 Europe
7.4.1 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.6 South America
7.6.1 South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.3.2 By Company, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.4.2 By Company, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.5.2 By Company, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.5.3 By Type, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.6.2 By Company, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.7.2 By Company, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.9.2 By Company, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.9.3 By Type, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Boston Scientific
9.1.1 Boston Scientific Company Information, Head Office, Market Area and Industry Position
9.1.2 Boston Scientific Company Profile and Main Business
9.1.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.1.4 Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.1.5 Boston Scientific Recent Developments
9.2 Agiliti Health, Inc.
9.2.1 Agiliti Health, Inc. Company Information, Head Office, Market Area and Industry Position
9.2.2 Agiliti Health, Inc. Company Profile and Main Business
9.2.3 Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.2.4 Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.2.5 Agiliti Health, Inc. Recent Developments
9.3 Endo Pharmaceuticals Inc.
9.3.1 Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
9.3.2 Endo Pharmaceuticals Inc. Company Profile and Main Business
9.3.3 Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.3.4 Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.3.5 Endo Pharmaceuticals Inc. Recent Developments
9.4 HealthTronics, Inc.
9.4.1 HealthTronics, Inc. Company Information, Head Office, Market Area and Industry Position
9.4.2 HealthTronics, Inc. Company Profile and Main Business
9.4.3 HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.4.4 HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.4.5 HealthTronics, Inc. Recent Developments
9.5 OmniGuide
9.5.1 OmniGuide Company Information, Head Office, Market Area and Industry Position
9.5.2 OmniGuide Company Profile and Main Business
9.5.3 OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.5.4 OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.5.5 OmniGuide Recent Developments
9.6 Olympus Corporation
9.6.1 Olympus Corporation Company Information, Head Office, Market Area and Industry Position
9.6.2 Olympus Corporation Company Profile and Main Business
9.6.3 Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.6.4 Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.6.5 Olympus Corporation Recent Developments
9.7 Richard Wolf GmbH
9.7.1 Richard Wolf GmbH Company Information, Head Office, Market Area and Industry Position
9.7.2 Richard Wolf GmbH Company Profile and Main Business
9.7.3 Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.7.4 Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.7.5 Richard Wolf GmbH Recent Developments
9.8 Lumenis
9.8.1 Lumenis Company Information, Head Office, Market Area and Industry Position
9.8.2 Lumenis Company Profile and Main Business
9.8.3 Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.8.4 Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.8.5 Lumenis Recent Developments
9.9 Urologix, LLC
9.9.1 Urologix, LLC Company Information, Head Office, Market Area and Industry Position
9.9.2 Urologix, LLC Company Profile and Main Business
9.9.3 Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.9.4 Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.9.5 Urologix, LLC Recent Developments
9.10 Coloplast Corp
9.10.1 Coloplast Corp Company Information, Head Office, Market Area and Industry Position
9.10.2 Coloplast Corp Company Profile and Main Business
9.10.3 Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.10.4 Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.10.5 Coloplast Corp Recent Developments
9.11 Medifocus Inc.
9.11.1 Medifocus Inc. Company Information, Head Office, Market Area and Industry Position
9.11.2 Medifocus Inc. Company Profile and Main Business
9.11.3 Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.11.4 Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.11.5 Medifocus Inc. Recent Developments
9.12 Biolitec
9.12.1 Biolitec Company Information, Head Office, Market Area and Industry Position
9.12.2 Biolitec Company Profile and Main Business
9.12.3 Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.12.4 Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.12.5 Biolitec Recent Developments
9.13 Teleflex Incorporated
9.13.1 Teleflex Incorporated Company Information, Head Office, Market Area and Industry Position
9.13.2 Teleflex Incorporated Company Profile and Main Business
9.13.3 Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.13.4 Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.13.5 Teleflex Incorporated Recent Developments
9.14 Urotech Devices
9.14.1 Urotech Devices Company Information, Head Office, Market Area and Industry Position
9.14.2 Urotech Devices Company Profile and Main Business
9.14.3 Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.14.4 Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.14.5 Urotech Devices Recent Developments
9.15 BD
9.15.1 BD Company Information, Head Office, Market Area and Industry Position
9.15.2 BD Company Profile and Main Business
9.15.3 BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.15.4 BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.15.5 BD Recent Developments
9.16 PROCEPT BioRobotics
9.16.1 PROCEPT BioRobotics Company Information, Head Office, Market Area and Industry Position
9.16.2 PROCEPT BioRobotics Company Profile and Main Business
9.16.3 PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.16.4 PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.16.5 PROCEPT BioRobotics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Restraints
Table 3. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Trends
Table 4. Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Policy
Table 5. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share by Company (2018-2023)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturers Product Type
Table 10. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company (2018-2023) & (US$ million)
Table 11. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Benign Prostatic Hyperplasia (BPH) Laser Therapy Upstream (Raw Materials)
Table 13. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Typical Customers
Table 14. Benign Prostatic Hyperplasia (BPH) Laser Therapy Typical Distributors
Table 15. By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2029
Table 22. Boston Scientific Company Information, Head Office, Market Area and Industry Position
Table 23. Boston Scientific Company Profile and Main Business
Table 24. Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 25. Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 26. Boston Scientific Recent Developments
Table 27. Agiliti Health, Inc. Company Information, Head Office, Market Area and Industry Position
Table 28. Agiliti Health, Inc. Company Profile and Main Business
Table 29. Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 30. Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 31. Agiliti Health, Inc. Recent Developments
Table 32. Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
Table 33. Endo Pharmaceuticals Inc. Company Profile and Main Business
Table 34. Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 35. Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 36. Endo Pharmaceuticals Inc. Recent Developments
Table 37. HealthTronics, Inc. Company Information, Head Office, Market Area and Industry Position
Table 38. HealthTronics, Inc. Company Profile and Main Business
Table 39. HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 40. HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 41. HealthTronics, Inc. Recent Developments
Table 42. OmniGuide Company Information, Head Office, Market Area and Industry Position
Table 43. OmniGuide Company Profile and Main Business
Table 44. OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 45. OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 46. OmniGuide Recent Developments
Table 47. Olympus Corporation Company Information, Head Office, Market Area and Industry Position
Table 48. Olympus Corporation Company Profile and Main Business
Table 49. Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 50. Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 51. Olympus Corporation Recent Developments
Table 52. Richard Wolf GmbH Company Information, Head Office, Market Area and Industry Position
Table 53. Richard Wolf GmbH Company Profile and Main Business
Table 54. Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 55. Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 56. Richard Wolf GmbH Recent Developments
Table 57. Lumenis Company Information, Head Office, Market Area and Industry Position
Table 58. Lumenis Company Profile and Main Business
Table 59. Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 60. Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 61. Lumenis Recent Developments
Table 62. Urologix, LLC Company Information, Head Office, Market Area and Industry Position
Table 63. Urologix, LLC Company Profile and Main Business
Table 64. Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 65. Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 66. Urologix, LLC Recent Developments
Table 67. Coloplast Corp Company Information, Head Office, Market Area and Industry Position
Table 68. Coloplast Corp Company Profile and Main Business
Table 69. Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 70. Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 71. Coloplast Corp Recent Developments
Table 72. Medifocus Inc. Company Information, Head Office, Market Area and Industry Position
Table 73. Medifocus Inc. Company Profile and Main Business
Table 74. Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 75. Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 76. Medifocus Inc. Recent Developments
Table 77. Biolitec Company Information, Head Office, Market Area and Industry Position
Table 78. Biolitec Company Profile and Main Business
Table 79. Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 80. Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 81. Biolitec Recent Developments
Table 82. Teleflex Incorporated Company Information, Head Office, Market Area and Industry Position
Table 83. Teleflex Incorporated Company Profile and Main Business
Table 84. Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 85. Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 86. Teleflex Incorporated Recent Developments
Table 87. Urotech Devices Company Information, Head Office, Market Area and Industry Position
Table 88. Urotech Devices Company Profile and Main Business
Table 89. Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 90. Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 91. Urotech Devices Recent Developments
Table 92. BD Company Information, Head Office, Market Area and Industry Position
Table 93. BD Company Profile and Main Business
Table 94. BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 95. BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 96. BD Recent Developments
Table 97. PROCEPT BioRobotics Company Information, Head Office, Market Area and Industry Position
Table 98. PROCEPT BioRobotics Company Profile and Main Business
Table 99. PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
Table 100. PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
Table 101. PROCEPT BioRobotics Recent Developments
List of Figure
Figure 1. Benign Prostatic Hyperplasia (BPH) Laser Therapy Picture
Figure 2. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share of Global
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Chain
Figure 10. Holmium Laser
Figure 11. Thulium Laser
Figure 12. Green Light Laser
Figure 13. Others
Figure 14. By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2029
Figure 16. Hospitals
Figure 17. Clinics
Figure 18. Others
Figure 19. By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, US$ Million
Figure 20. By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2029
Figure 21. By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2029
Figure 22. North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
Figure 24. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
Figure 26. Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
Figure 28. South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2018-2023
Figure 30. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 32. By Company, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 33. By Type, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 34. By Application, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 35. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 36. By Company, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 37. By Type, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 38. By Application, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 39. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 40. By Company, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 41. By Type, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 42. By Application, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 43. Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 44. By Company, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 45. By Type, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 46. By Application, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 47. South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 48. By Company, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 49. By Type, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 50. By Application, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 51. Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 52. By Company, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 53. By Type, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 54. By Application, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 55. India Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 56. By Company, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 57. By Type, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 58. By Application, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 59. Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue, 2018-2029, (US$ Million)
Figure 60. By Company, Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share, 2018-2023
Figure 61. By Type, Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 62. By Application, Middle East & Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share, 2022 VS 2029
Figure 63. Research Methodology
Figure 64. Breakdown of Primary Interviews
Figure 65. Bottom-up Approaches
Figure 66. Top-down Approaches
Research Methodology:
Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|